These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice. Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965 [TBL] [Abstract][Full Text] [Related]
27. The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice. Libinaki R; Vinh A; Tesanovic-Klajic S; Widdop R; Gaspari T Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():107-116. PubMed ID: 28744946 [TBL] [Abstract][Full Text] [Related]
28. Social disruption stress increases IL-6 levels and accelerates atherosclerosis in ApoE-/- mice. Bernberg E; Ulleryd MA; Johansson ME; Bergström GM Atherosclerosis; 2012 Apr; 221(2):359-65. PubMed ID: 22284955 [TBL] [Abstract][Full Text] [Related]
29. Training-induced anti-atherosclerotic effects are associated with increased vascular PPARgamma expression in apolipoprotein E-deficient mice. Szostak J; Miguet-Alfonsi C; Berthelot A; Laurant P Acta Physiol (Oxf); 2016 Feb; 216(2):221-30. PubMed ID: 26467845 [TBL] [Abstract][Full Text] [Related]
30. AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction. Huang Q; Qin L; Dai S; Zhang H; Pasula S; Zhou H; Chen H; Min W Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):795-804. PubMed ID: 23413429 [TBL] [Abstract][Full Text] [Related]
31. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling. Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821 [TBL] [Abstract][Full Text] [Related]
32. Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice. Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Pugliese G Diabetologia; 2015 Apr; 58(4):845-53. PubMed ID: 25471794 [TBL] [Abstract][Full Text] [Related]
33. Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice. Wei H; Zhang WJ; McMillen TS; Leboeuf RC; Frei B Atherosclerosis; 2012 Aug; 223(2):306-13. PubMed ID: 22770994 [TBL] [Abstract][Full Text] [Related]
34. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098 [TBL] [Abstract][Full Text] [Related]
35. Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice. Shnerb Ganor R; Harats D; Schiby G; Gailani D; Levkovitz H; Avivi C; Tamarin I; Shaish A; Salomon O Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):475-81. PubMed ID: 26800563 [TBL] [Abstract][Full Text] [Related]
37. P-Selectin Expressed by a Human SELP Transgene Is Atherogenic in Apolipoprotein E-Deficient Mice. Zhang N; Liu Z; Yao L; Mehta-D'souza P; McEver RP Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1114-21. PubMed ID: 27102967 [TBL] [Abstract][Full Text] [Related]
38. Noninvasive assessment of atherosclerosis in apolipoprotein-e knockout mice by ultrasound biomicroscopy. Wang Y; Yang Y; Xie J; Li Z; Zhang X; Li R Ultrasound Med Biol; 2011 Jun; 37(6):892-9. PubMed ID: 21601134 [TBL] [Abstract][Full Text] [Related]
39. Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo. Heim C; Gebhardt J; Ramsperger-Gleixner M; Jacobi J; Weyand M; Ensminger SM Heart Vessels; 2016 May; 31(5):783-94. PubMed ID: 26062773 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice. Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]